INTRODUCTION
Systemic candidiasis is the 4th leading cause of hospitalacquired sepsis in the United States, making these infections as common as those caused by enteric Gram-negative bacilli [1] . A report on neonatal late-onset sepsis in the Eunice Kennedy Shriver National Institute for Child Health and Human Development Neonatal Research Network identified Candida as the cause of 12% of these infections [2] ; however, in recent years, a decrease in incidence of invasive fungal infections (IFIs) in children has been reported in the United States [3] . Premature neonates are immunocompromised patients that are vulnerable to long-term complications from invasive candidiasis. Up to 30% of premature infants with invasive candidiasis die, and survivors have severe neurodevelopmental morbidity [4] . Among other predictors, colonization with yeast at multiple sites is associated with invasive infection in infants [5, 6] . Candida albicans and Candida parapsilosis are the most common species to colonize and infect patients in the neonatal intensive care unit (NICU). Factors affecting their colonization and infection have only been examined to a limited extent in the NICU.
Colonization with yeast has several likely sources, some of which are unique to newborns. One exposure unique to newborns is the microflora of the maternal reproductive tract. Studies confirm vertical transmission of colonizing C albicans, but a study of colonization among motherpremature infant pairs found 22% of infants were colonized with C parapsilosis compared to just 1.3% of their mothers, suggesting colonization after birth [7] . Another exposure unique to neonates is breast milk, which has received limited study with respect to its potential role in Candida colonization. One study failed to isolate C albicans in breast milk expressed from mothers with clinical signs of breast ductal candidiasis; however, the skin surface was cleansed aseptically before sampling [8] .
Another study concluded that receipt of breast milk was associated with C albicans colonization but not colonization with non-albicans Candida species [9] . Mechanisms of colonization were not explored.
Other sources of colonization include many environmental exposures in the NICU setting. The results of previous studies have demonstrated acquisition from healthcare workers' hands [10, 11] and from fomites [10] . In addition, acquisition of microflora could occur from skinon-skin contact from family members.
Prophylactic medications, both systemic and mucosal, for prevention of IFIs aim to decrease IFI and additionally decrease fungal colonization. The best-studied agent for systemic prophylaxis is fluconazole. A meta-analysis showed a net benefit for fluconazole prophylaxis in preventing IFI, particularly in centers with high incidence of IFI [12] . However, the incidence of IFI varies markedly among centers, making a universal strategy for prophylaxis difficult to develop. Other studies on mucosal medications such as nystatin and miconazole show similar benefit, but they suffer from lack of rigorous study design [13] . Current guidelines suggest careful selection of prophylactic agents, taking into account local epidemiology and incidence of IFI in the NICU [14] .
In this study, infants admitted to the NICU were tested for colonization with Candida species to test the hypothesis that expressed human breast milk is a vehicle for colonization of infants with Candida. In addition, we report correlates with colonization with C parapsilosis and C albicans.
METHODS
In this prospective cohort study, infants were enrolled from the NICU at Women & Infants Hospital of Rhode Island. Any infant admitted with a minimum stay of 72 hours was eligible for the study. Exclusion criteria included death, transfer, or discharge from the NICU at less than 72 hours of age and lack of parental informed consent. After parental informed consent was obtained, standard commercial culture swabs were used to obtain samples from 3 sites-oral, inguinal, and rectal-at enrollment and then weekly for 12 weeks, or until the patient exited the study due to hospital discharge, transfer to another hospital, or death. Expressed maternal breast milk was also obtained weekly, when available, at enrollment and for 12 weeks or until the patient exited the study. Expressed breast milk was obtained from the daily supply, and may have been freshly expressed and refrigerated, or may have been frozen and thawed prior to being refrigerated. Patients who had a hospital admission longer than 12 weeks were followed for clinical outcomes, but no additional cultures were obtained. Clinical information was extracted from the medical records. The study was approved by the Institutional Review Board of Women & Infants Hospital, and data extraction and storage complied with the Health Information Portability and Accountability Act of 1996.
Samples were cultured on YPD agar media (1% yeast extract, 2% peptone, 2% dextrose, 2% agar) containing 100 µg/mL streptomycin and 50 µg/mL ampicillin to inhibit bacterial growth. Yeast isolated from culture were incubated in Medium-199 (Lonza, Basel, Switzerland) at 37°C for 3 hours to induce germ-tube formation. Yeast that produced germ-tubes were classified as C albicans, and 1 sample per study subject was confirmed using the Vitek-2 system (bioMérieux, Marcy-L'Étoile, France). All nongerm-tube producing yeast were further speciated using the Vitek-2 system. An infant was considered to be colonized if any culture swab was found to be positive for yeast. Several different feeding modalities (via nasogastric tube, bottle feeding, or direct nursing) were utilized in study subjects as directed by the medical team.
Statistical Analysis
Analysis was performed using Stata 11.2 (StataCorp, College Station, TX). Univariate analysis was performed using Fisher's exact test or Pearson's χ 2 test for categorical variables, and Wilcoxon rank-sum was used for continuous variables. A 2-sided P value <.05 was considered statistically significant. Variables with potential colinearity were examined in groups of similar domains to determine the variable with the largest potential effect, determined by greatest significant odds ratio, on the measured outcomes. The variables with largest effect were then placed into a final logistic regression model for each measured outcome. Hosmer-Lemeshow goodness-of-fit tests were performed for all models, with P values ranging from .06 to .45. Linearity of continuous variables was assessed in each model, with good linearity noted.
RESULTS
One hundred thirty patients from 2276 total admissions during this time period were recruited from February 2011 to November 2012. Follow up extended through December 2012. Cultures were obtained on 129 subjects; cultures were unable to be obtained from 1 patient due to medical instability. Of 130 patients, 73 (56.2%) were male ( Table 1 ). The median gestational age was 34.4 weeks (interquartile range [IQR], 33.1-37.1 weeks). Ninety-three (71.5%) were born at less than 37 weeks gestational age. The median birth weight was 2157.5 g (IQR, 1740-3060 g). The demographics of the study population were representative of all admissions over the same time period. The vast majority (125, 96.2%) were discharged home, whereas 2 (1.5%) died and 3 (2.3%) were transferred to other healthcare facilities. During the study period, there were 4 cases of invasive candidiasis identified in this NICU, 2 from blood cultures (C albicans and Candida glabrata) and 2 from urine cultures only (C albicans and Candida tropicalis). No patients in this study developed IFI.
Antifungal prophylaxis was not used routinely in this NICU. In the study population, no patients received systemic antifungal agents for either treatment or prophylactic indications (amphotericin B, a triazole antifungal, or an echinocandin). One patient received topical nystatin for 12 days for dermatitis. Regarding antibiotic use, 2 patients each received a second-generation cephalosporin and metronidazole. One patient received meropenem, and no patients received third-or fourth-generation cephalosporins.
Twenty-nine infants (22%) were colonized with any species of yeast (Table 1) . Variables associated with colonization in univariate analysis included receipt of antenatal steroids, receipt of postnatal antibiotics, and receipt of breast milk that was colonized with yeast. Other potential correlates with colonization included longer hospital stay (P = .054), birth weight under 2000 g (P = .07), and having surgery (P = .098). No colonized infant had received a systemic or topical antifungal medication or third-or fourthgeneration cephalosporin. Details of colonization timeline and species are included in Supplementary Table 1 . The majority of samples had concordant species of yeast isolated from each site for each time point; however, the colonizing Candida species changed over time in 2 cases.
Further analysis was performed on the 8 patients colonized with C parapsilosis (Table 2 ). Compared to the remaining 122 patients, infants colonized with C parapsilosis were less likely to be male, more likely to have been born at a gestational age under 30 weeks, have a birth weight under 2000 g, have very low (<1500 g) or extremely low (<1000 g) birth weight, have received postnatal steroids, have received breast milk colonized with yeast, or have received blood products. In addition, they were more likely to have devices such as a nasogastric or orogastric tube, endotracheal tube, central venous catheter, bladder catheter, or have had surgery.
Compared to infants colonized with C albicans (Table 3) , infants colonized with C parapsilosis were more likely to have received breast milk colonized with yeast. They also tended to have younger mothers, which is of unclear clinical significance. There were no other differences found on univariate analysis. Comparisons to infants colonized with C glabrata and Candida lusitaniae were not made due to small numbers of infants colonized with those species. There were no differences detected in infants with multisite colonization (2 or more sites at a time colonized) versus single-site colonization (Supplementary Table 2) .
After examining the characteristics of isolates of yeast obtained from maternal breast milk, researchers isolated 4 species (Table 4) . In these cases, only 3 of 10 infants had the same species of yeast isolated from surface cultures as they did from the breast milk that they received.
The results of multivariable analysis are shown in Table 5 . For colonization status, several potentially colinear variables were examined. Gestational age was the colinear variable that was most likely to confound other findings. In a multivariable analysis, maternal receipt of antenatal steroids and infant receipt of breast milk colonized with yeast were found to be statistically significantly associated with infant colonization. Multivariable analysis was performed in a similar fashion, comparing infants colonized with C parapsilosis with both the remainder of the population and infants colonized with other yeast. Increasing length of stay was found to have a statistically significant association with colonization by C parapsilosis. Risk for colonization increased 2.4% per day of hospitalization. In addition, receipt of maternal breast milk colonized with yeast was found to have a significant association with C parapsilosis colonization. After analyzing C albicans colonized infants and comparing them with the remainder of the population, we found that the only correlate with colonization that remained after multivariable analysis was maternal receipt of antenatal steroids. For comparison of the populations colonized with C albicans versus the population colonized with C parapsilosis, no potential correlates remained after multivariable analysis, probably due to the small numbers of patients in each group.
DISCUSSION
This study shows an association between receipt of breast milk from which yeast are isolated and colonization with yeast in a neonatal population. This study is unique in that it is a dedicated study with a large cohort that examines breast milk as a possible mode of colonization, and it provides longitudinal data on the variation of colonization over time. Surprisingly, there is a low concordance rate (30%) between the species isolated from breast milk and those isolated from the infants' cultures, which demonstrates that pathways yet to be identified are involved in colonization with yeast. This result raises the possibility that, although maternal breast milk may be a source of colonizing yeast, there may be a more complex interaction between the mother, the breast milk produced, and the infant. Speculation as to the clinical importance of the findings of this study would be premature; however, it is possible that examining components of breast milk may yield additional insight into the process of colonization of neonates with yeast. Given the low rate of IFI at baseline in this NICU population, recommendations on breast feeding or changes to handling of expressed breast milk cannot be made. The vast majority of mothers in this NICU population provide breast milk for their infants. As such, it is difficult to draw conclusions comparing breast feeding to formula feeding from this study. Human milk is the preferred nutrition for all infants. Breast milk is known to have many immunologic and antimicrobial components including immunoglobulins, lactoferrin, lysozyme, mucins, dermidicin, and clusterin [15] . Several of these proteins have been shown to have inhibitory effects on yeast, either by a directly fungicidal effect [16] or through inhibition of colonization in human mucosae [17] . One possibility is that a component or multiple components in concert could inhibit growth of yeast in breast milk itself. In addition, supplemental bovine lactoferrin has been shown to decrease the incidence of IFI in premature neonates [18] . However, to our knowledge, no studies have been published on the effect of human lactoferrin, either as supplements or as received through breast feeding. Colonization with yeast in the NICU is likely a complex process. Because many factors are difficult to control in a clinical setting, this study has important limitations. There are many potential sources where colonizing yeast can be acquired by the infant, either from fomites, devices used in medical care, contact from medical providers, or contact with family members. Data regarding each of these points of contact were not able to be collected in the course of this study. Likewise, there are multiple potential sources for inoculation of breast milk. The most likely source of inoculation of the breast milk is from skin colonization of the mothers. This study did not collect data on maternal skin colonization. It is possible that the yeast isolated from breast milk originated from an environmental source other than the mother's skin, such as from the breast pump equipment or from handling after the milk was expressed. The methods of this study reflected "real-world" conditions in that the handling of breast milk likely varied somewhat from patient to patient. Mothers with infants in the Associations reported with particular species should be interpreted with caution. The small number of isolates obtained per species impairs the interspecies comparisons. It is also notable that the associations reported do not imply causation, because colonization may predate some of the correlates reported.
The culture techniques used in this study are currently standard practice. It is possible that very low numbers of colonizing yeast may have been missed by the methods used. In subsequent studies, molecular techniques could be used to examine colonizing yeast as part of the neonatal microbiome. However, a limitation of molecular techniques is that biologic activity cannot be assured, but rather it is inferred from the quantity of nucleic acid obtained. Although it is possible the methods used were less sensitive than molecular techniques, recovery of living organisms makes biologic activity in vivo more likely. In addition, our primary interest was in Candida species that are readily recoverable by culture-based methods. This study can provide a reference point for fungal species in term and preterm infants for future molecular studies.
The clinical implications of colonization have previously been described as predictors for invasive disease. At baseline in our NICU, there is a low rate (<0.2%) of invasive Candida infection, which makes invasive infection difficult to include as an outcome. Our reported rate of 22% colonization in a NICU is similar to other reported rates in the United States [19] .
Our finding of an association of infant colonization with the use of antenatal steroids was surprising, but it may be confounded by gestational age and low birth weight despite attempts to control for these effects in our models. Currently, the benefits of administering antenatal steroids in preterm labor far outweigh the possible risks. Several large studies have shown benefit in administering antenatal steroids in terms of lung maturation and reduction in the incidence of respiratory distress syndrome [20, 21] as well as affording neuroprotection and improving overall neurodevelopmental outcomes [22] . However, the results of previous studies have also shown an association with multiple courses of antenatal steroids and early onset neonatal sepsis [23, 24] . Animal models have shown longer lasting effects on the infant hypothalamic-pituitary axis [25] . These latter studies suggest that there may be unintended consequences of antenatal steroids. It is possible that steroids act as a broadly acting immunosuppressant and anti-inflammatory agent, and they could subtly alter the neonatal immune system without a resulting increase in invasive infections, or they could alter the neonatal microbiome.
This study raises additional questions about the role of breast milk in colonization of infants with yeast that, to our knowledge, have not been reported previously. Because there was discordance between species recovered from breast milk and species colonizing infants, the recovery of yeast from breast milk may be a marker of an additional underlying process in the mother. One such area that could be explored may be the immunomodulatory properties of the expressed breast milk. Colonization of breast milk could also be a marker of maternal susceptibility to infection or colonization. Future studies could be designed to more rigorously examine these potential issues.
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